Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Levetiracetam in tardive dyskinesia.
Meco G, Fabrizio E, Epifanio A, Morgante F, Valente M, Vanacore N, Di Rosa AE, Morgante L. Meco G, et al. Among authors: morgante l, morgante f. Clin Neuropharmacol. 2006 Sep-Oct;29(5):265-8. doi: 10.1097/01.WNF.0000228807.49044.7D. Clin Neuropharmacol. 2006. PMID: 16960471 Clinical Trial.
Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis.
Morgante L, Epifanio A, Spina E, Zappia M, Di Rosa AE, Marconi R, Basile G, Di Raimondo G, La Spina P, Quattrone A. Morgante L, et al. Clin Neuropharmacol. 2004 Jul-Aug;27(4):153-6. doi: 10.1097/01.wnf.0000136891.17006.ec. Clin Neuropharmacol. 2004. PMID: 15319699 Clinical Trial.
[¹²³I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism.
Tinazzi M, Cipriani A, Matinella A, Cannas A, Solla P, Nicoletti A, Zappia M, Morgante L, Morgante F, Pacchetti C, Sciarretta M, Dallocchio C, Rossi S, Malentacchi M, Ceravolo R, Frosini D, Sestini S, Bovi T, Barbui C. Tinazzi M, et al. Among authors: morgante l, morgante f. Schizophr Res. 2012 Aug;139(1-3):40-5. doi: 10.1016/j.schres.2012.06.003. Epub 2012 Jun 20. Schizophr Res. 2012. PMID: 22727453
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study.
Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, Simoni L, Marconi R; PRIAMO STUDY GROUP. Colosimo C, et al. Among authors: morgante l. J Neurol. 2010 Jan;257(1):5-14. doi: 10.1007/s00415-009-5255-7. Epub 2009 Aug 9. J Neurol. 2010. PMID: 19669613
Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression.
Morgante L, Colosimo C, Antonini A, Marconi R, Meco G, Pederzoli M, Pontieri FE, Cicarelli G, Abbruzzese G, Zappulla S, Ramat S, Manfredi M, Bottacchi E, Abrignani M, Berardelli A, Cozzolino A, Paradiso C, De Gaspari D, Morgante F, Barone P; PRIAMO Study Group. Morgante L, et al. Among authors: morgante f. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):76-82. doi: 10.1136/jnnp-2011-300043. Epub 2011 Aug 11. J Neurol Neurosurg Psychiatry. 2012. PMID: 21836035
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
Pellecchia MT, Longo K, Pivonello R, Lucetti C, Marchese R, Spampani A, Manfredi M, Epifanio A, Sensi M, Scaravilli T, Bracco F, Eleopra R, Morgante L, Donati E, Marconi R, Abbruzzese G, Bonuccelli U, Zappia M, Colao A, Barone P. Pellecchia MT, et al. Among authors: morgante l. Ann Neurol. 2006 Nov;60(5):611-615. doi: 10.1002/ana.20956. Ann Neurol. 2006. PMID: 16958123
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
Pellecchia MT, Longo K, Manfredi M, Lucetti C, Cossu G, Petrone A, Marconi R, Sensi M, Epifanio A, Eleopra R, Marchese R, Scaravilli T, Morgante L, Abbruzzese G, Bonuccelli U, Donati E, Pivonello R, Colao A, Barone P. Pellecchia MT, et al. Among authors: morgante l. Mov Disord. 2008 Jan 30;23(2):190-4. doi: 10.1002/mds.21700. Mov Disord. 2008. PMID: 18044703
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: a 2-year follow-up multicenter study.
Tinazzi M, Morgante F, Matinella A, Bovi T, Cannas A, Solla P, Marrosu F, Nicoletti A, Zappia M, Luca A, Di Stefano A, Morgante L, Pacchetti C, Minafra B, Sciarretta M, Dallocchio C, Rossi S, Ulivelli M, Ceravolo R, Frosini D, Cipriani A, Barbui C. Tinazzi M, et al. Among authors: morgante l, morgante f. Schizophr Res. 2014 Feb;152(2-3):344-9. doi: 10.1016/j.schres.2013.11.028. Epub 2013 Dec 25. Schizophr Res. 2014. PMID: 24369987
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire.
Morgante L, Morgante F, Moro E, Epifanio A, Girlanda P, Ragonese P, Antonini A, Barone P, Bonuccelli U, Contarino MF, Capus L, Ceravolo MG, Marconi R, Ceravolo R, D'Amelio M, Savettieri G. Morgante L, et al. Among authors: morgante f. Parkinsonism Relat Disord. 2007 Dec;13(8):528-31. doi: 10.1016/j.parkreldis.2006.12.013. Epub 2007 Mar 7. Parkinsonism Relat Disord. 2007. PMID: 17347021
142 results